Rein Therapeutics, Inc. Interest and Other Income
Rein Therapeutics, Inc. (RNTX) reported Interest and Other Income of $167.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2017-11-09
- Rein Therapeutics, Inc. interest and other income for the quarter ending 2017-09-30 was $167.00K, a 1570.00% increase year-over-year.
- Rein Therapeutics, Inc. interest and other income for the quarter ending 2017-06-30 was $29.00K, a 81.25% increase year-over-year.
- Rein Therapeutics, Inc. interest and other income for the quarter ending 2016-09-30 was $10.00K.
- Rein Therapeutics, Inc. interest and other income for the quarter ending 2016-06-30 was $16.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month |
|---|---|---|---|
| 2017-09-30 | $167.00K 10-Q · filed 2017-11-09 | $196.00K derived: sum of 2 quarters · filed 2017-11-09 | $228.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $29.00K 10-Q · filed 2017-08-10 | $61.00K 10-Q · filed 2017-08-10 | |
| 2016-09-30 | $10.00K 10-Q · filed 2017-11-09 | $26.00K derived: sum of 2 quarters · filed 2017-11-09 | $40.00K 10-Q · filed 2017-11-09 |
| 2016-06-30 | $16.00K 10-Q · filed 2017-08-10 | $30.00K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |